EP1430302A4 - Inhibitors of glycosaminoglycans - Google Patents

Inhibitors of glycosaminoglycans

Info

Publication number: EP1430302A4
Authority: EP; European Patent Office
Prior art keywords: glycosaminoglycans; inhibitors
Prior art date: 2001-03-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02728711A

Other languages

German (de)

French (fr)

Other versions

EP1430302A2 (en

Inventor

Akira Takashima

Mark E Mummert

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Texas System

Original Assignee

University of Texas System

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-21

Filing date

2002-03-20

Publication date

2007-08-22

2002-03-20 Application filed by University of Texas System filed Critical University of Texas System

2004-06-23 Publication of EP1430302A2 publication Critical patent/EP1430302A2/en

2007-08-22 Publication of EP1430302A4 publication Critical patent/EP1430302A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

EP02728711A 2001-03-21 2002-03-20 Inhibitors of glycosaminoglycans Withdrawn EP1430302A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27779001P	2001-03-21	2001-03-21
US277790P		2001-03-21
PCT/US2002/011167 WO2002076173A2 (en)	2001-03-21	2002-03-20	Inhibitors of glycosaminoglycans

Publications (2)

Publication Number	Publication Date
EP1430302A2 EP1430302A2 (en)	2004-06-23
EP1430302A4 true EP1430302A4 (en)	2007-08-22

Family

ID=23062353

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02728711A Withdrawn EP1430302A4 (en)	2001-03-21	2002-03-20	Inhibitors of glycosaminoglycans

Country Status (5)

Country	Link
EP (1)	EP1430302A4 (en)
JP (1)	JP2004532203A (en)
AU (1)	AU2002258749A1 (en)
CA (1)	CA2439409A1 (en)
WO (1)	WO2002076173A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2720587A1 (en)	2008-04-09	2009-10-15	Francis Barany	Coferons and methods of making and using them
CA2774476A1 (en)	2009-10-07	2011-04-14	Francis Barany	Coferons and methods of making and using them
EP2804586A4 (en) *	2012-01-19	2016-03-16	Univ Johns Hopkins	Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996040189A1 (en) *	1995-06-07	1996-12-19	Glaxo Group Limited	Peptides and compounds that bind to a receptor
EP0950708A2 (en) *	1997-12-19	1999-10-20	Cangene Corporation	Enhanced affinity hyaluronan binding peptides
WO2000057896A1 (en) *	1999-03-26	2000-10-05	The University Of Texas System	Modulators of polysaccharides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5643575A (en) *	1993-10-27	1997-07-01	Enzon, Inc.	Non-antigenic branched polymer conjugates
WO1997009051A1 (en) *	1995-09-05	1997-03-13	Cambridge Neuroscience, Inc.	Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
EP1169048A4 (en) *	1998-07-06	2002-07-17	Glenn D Prestwich	Hyaluronic acid mimics and methods related thereto
AU4529800A (en) *	1999-05-05	2000-11-21	Neurochem, Inc.	Stereoselective antifibrillogenic peptides and peptidomimetics thereof

2002
- 2002-03-20 WO PCT/US2002/011167 patent/WO2002076173A2/en active Search and Examination
- 2002-03-20 EP EP02728711A patent/EP1430302A4/en not_active Withdrawn
- 2002-03-20 JP JP2002574703A patent/JP2004532203A/en active Pending
- 2002-03-20 CA CA002439409A patent/CA2439409A1/en not_active Abandoned
- 2002-03-20 AU AU2002258749A patent/AU2002258749A1/en not_active Abandoned

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996040189A1 (en) *	1995-06-07	1996-12-19	Glaxo Group Limited	Peptides and compounds that bind to a receptor
EP0950708A2 (en) *	1997-12-19	1999-10-20	Cangene Corporation	Enhanced affinity hyaluronan binding peptides
WO2000057896A1 (en) *	1999-03-26	2000-10-05	The University Of Texas System	Modulators of polysaccharides and uses thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CARRITHERS M D ET AL: "SYNTHESIS AND CHARACTERIZATION OF BIVALENT PEPTIDE LIGANDS TARGETED TO G-PROTEIN-COUPLED RECEPTORS", CHEMISTRY AND BIOLOGY, CURRENT BIOLOGY, LONDON, GB, vol. 3, no. 5, May 1996 (1996-05-01), pages 537 - 542, XP000945385, ISSN: 1074-5521 *
MUMMERT M E ET AL: "Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking.", THE JOURNAL OF EXPERIMENTAL MEDICINE 18 SEP 2000, vol. 192, no. 6, 18 September 2000 (2000-09-18), pages 769 - 779, XP009081295, ISSN: 0022-1007 *
TAKASHIMA A ET AL: "NEW TECHNOLOGIES TO PREVENT AND TREAT CONTACT HYPERSENSITIVITY RESPONSES", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, NEW YORK ACADEMY OF SCIENCES, NEW YORK, NY, US, vol. 919, 2000, pages 205 - 213, XP009060432, ISSN: 0077-8923 *

Also Published As

Publication number	Publication date
WO2002076173A2 (en)	2002-10-03
JP2004532203A (en)	2004-10-21
AU2002258749A1 (en)	2002-10-08
CA2439409A1 (en)	2002-10-03
WO2002076173A3 (en)	2004-04-08
EP1430302A2 (en)	2004-06-23

Legal Events

Date	Code	Title	Description
2004-05-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-06-23	17P	Request for examination filed	Effective date: 20031014
2004-06-23	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
2004-06-23	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2007-08-22	A4	Supplementary search report drawn up and despatched	Effective date: 20070720
2007-12-19	17Q	First examination report despatched	Effective date: 20071115
2008-08-22	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2008-09-24	18D	Application deemed to be withdrawn	Effective date: 20080326

Publication	Publication Date	Title
HK1208446A1 (en)	2016-03-04	Derivatives of uk-2a uk-2a
HK1061030A1 (en)	2004-09-03	Rho-kinase inhibitors
HK1061029A1 (en)	2004-09-03	Rho-kinase inhibitors
PL370909A1 (en)	2005-05-30	Cis-imidazolines as mdm2 inhibitors
HK1077762A1 (en)	2006-02-24	INHIBITORS OF TFGβ
AU2002305205A1 (en)	2002-11-05	9-deazaguanine derivatives as inhibitors of gsk-3
AU2002350217A8 (en)	2003-06-17	Glycinamides as factor xa inhibitors
HK1070352A1 (en)	2005-06-17	Indole-2-carboxamides as factor xa inhibitors
IL149118A0 (en)	2002-11-10	Inhibitors of neuraminidases
GB0025782D0 (en)	2000-12-06	Use of inhibitors
HK1066546A1 (en)	2005-03-24	Trifluoromethylpurines as phosphodiesterase 4 inhibitors
PL363391A1 (en)	2004-11-15	Phthalayinone-piperidino-derivatives as pde4 inhibitors
AU2002220241A1 (en)	2002-06-11	Parb inhibitors
HUP0300061A3 (en)	2005-09-28	Use of il-18 inhibitors
IL165475A0 (en)	2006-01-15	Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0202254D0 (en)	2002-03-20	Prevention of scarring
IL162454A0 (en)	2005-11-20	Pyrrolidine-2-ones as factor xa inhibitors
HUP0401641A3 (en)	2007-02-28	Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2002338734A1 (en)	2003-07-03	Use of phosphorodiesterase IV inhibitors
EP1430302A4 (en)	2007-08-22	Inhibitors of glycosaminoglycans
HUP0303185A3 (en)	2008-12-29	Glyt-1 inhibitors
IL160230A0 (en)	2004-07-25	Use of il-18 inhibitors
AU2002305868A1 (en)	2002-12-23	Inhibitors of reggamma
EP1364653A4 (en)	2005-01-26	Casoase 3 inhibitors
AU2002221882A1 (en)	2002-06-03	Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors